Spermosens Feed

2026-01-16 10:22:48 Spermosens and Sapyen sign Memorandum of Understanding to advance male fertility diagnostics

2025-12-09 08:45:00 Spermosens shares progress and plans for partner-driven commercialization 0,01 SEK | 0,00% | 0,03 MSEK

2025-12-08 13:41:04 Spermosens announces outcome of exercise of warrants series TO 4 0,01 SEK | 0,00% | 0,01 MSEK

2025-11-24 17:12:45 Spermosens announces last day of trading for warrants of series TO 4 0,01 SEK | +3,33% | 0,03 MSEK

2025-11-18 10:21:38 Spermosens receives patent approval in China 0,01 SEK | -9,38% | 0,16 MSEK

2025-11-12 09:04:13 Spermosens AB (publ) INTERIM REPORT JANUARY - SEPTEMBER 2025 0,01 SEK | +3,33% | 0,04 MSEK

2025-11-04 17:21:40 Spermosens receives patent approval in Israel 0,01 SEK | 0,00% | 0,04 MSEK

2025-11-03 12:31:53 Spermosens receives patent approval in Mexico 0,01 SEK | -3,13% | 0,05 MSEK

2025-10-22 11:17:42 Spermosens receives patent approval in Canada 0,01 SEK | 0,00% | 0,12 MSEK

2025-08-20 09:38:38 Spermosens AB (publ) INTERIM REPORT JANUARY - JUNE 2025 0,01 SEK | 0,00% | 0,02 MSEK

2025-08-07 08:30:00 Spermosens provides status update following successful clinical study 0,01 SEK | -2,78% | 0,03 MSEK

2025-06-17 14:16:07 Spermosens announces outcome of exercise of warrants series TO 5 0,01 SEK | +7,69% | 0,06 MSEK

2025-06-16 11:15:42 Spermosens AB Announces Results from Annual General Meeting on 16 June 2025 0,01 SEK | 0,00% | 0,05 MSEK

2025-06-13 13:04:02 Chairman and CEO of Spermosens exercise TO5 warrants 0,01 SEK | -9,30% | 0,16 MSEK

2025-06-11 12:48:55 Spermosens concludes clinical study with statistically significant results supporting the diagnostic value of JUNO-Checked 0,01 SEK | +28,57% | 1,70 MSEK

2025-06-05 21:09:15 Spermosens: The capital raise and issue announced in March 2025 is approved by Inspectorate of Strategic Products

2025-06-05 12:27:34 Last day of trading in warrants series TO 5 in Spermosens is 12 June 2025 0,01 SEK | 0,00% | 0,04 MSEK

2025-06-02 08:45:00 Spermosens: The subscription price for warrants of series TO 5 has been determined - the exercise period begins today 0,01 SEK | -15,38% | 0,14 MSEK

2025-05-26 12:06:17 Spermosens publishes annual report for the financial year 2024 0,01 SEK | 0,00% | 0,02 MSEK

2025-05-26 12:04:18 Spermosens publicerar årsredovisning för räkenskapsåret 2024 0,01 SEK | 0,00% | 0,02 MSEK

2025-05-15 08:51:00 Spermosens: NOTICE OF ANNUAL GENERAL MEETING 2025 IN SPERMOSENS AB (publ) 0,01 SEK | -2,50% | 0,01 MSEK

2025-05-15 08:50:00 Spermosens: KALLELSE TILL ÅRSSTÄMMA 2025 I SPERMOSENS AB (publ) 0,01 SEK | -2,50% | 0,01 MSEK

2025-05-07 09:10:43 Spermosens AB (publ)INTERIM REPORT JANUARY - MARCH 2025 0,01 SEK | 0,00% | 0,04 MSEK

2025-04-30 12:48:53 Spermosens provides update on clinical progress, partner discussions and financing 0,01 SEK | +10,81% | 0,03 MSEK

2025-04-02 09:56:37 Spermosens reports positive second interim results from clinical study 0,01 SEK | -6,12% | 0,75 MSEK

2025-03-31 08:45:00 Spermosens appoints Dr. Jaime Castillo-León as chief technology officer to drive innovation and technology development 0,01 SEK | +2,17% | 0,06 MSEK

2025-03-27 09:56:40 Spermosens AB announces strategic collaboration with Scalania AG to accelerate development and market readiness 0,01 SEK | 0,00% | 0,20 MSEK

2025-03-21 12:28:19 Spermosens publishes peer-reviewed article on JUNO-Checked technology 0,01 SEK | +6,98% | 0,04 MSEK

2025-03-14 12:44:05 Spermosens presents plan to achieve positive cash flow following recent strategic investment 0,01 SEK | +17,07% | 0,48 MSEK

2025-03-05 14:30:32 Spermosens announces outcome of TO3 warrants 0,01 SEK | 0,00% | 0,32 MSEK

2025-03-04 13:33:03 Spermosens secures SEK 10.8 million strategic investment through directed issue, fulfilling capital need until cash positive 0,01 SEK | +14,29% | 2,34 MSEK

2025-02-24 15:49:24 Spermosens announces last day of trading for warrants of series TO3 0,01 SEK | -2,50% | 0,01 MSEK

2025-02-19 15:54:38 Spermosens AB announces shareholding changes following latest directed issue 0,01 SEK | +2,50% | 0,01 MSEK

2025-02-17 16:00:00 Announcement from the Extraordinary General Meeting of Spermosens AB (publ) on 17 February 2025 0,01 SEK | 0,00% | 0,06 MSEK

2025-02-17 16:00:00 Kommuniké från extra bolagsstämma i Spermosens AB (publ) den 17 februari 2025 0,01 SEK | 0,00% | 0,06 MSEK

2025-02-13 20:54:06 Spermosens AB (publ) YEAR-END REPORT JANUARY - DECEMBER 2024 0,01 SEK | -2,44% | 0,01 MSEK

2025-02-13 13:26:49 Spermosens adjusts publication date for Year-end report 2024 0,01 SEK | +2,50% | 0,01 MSEK

2025-01-15 14:45:00 Kallelse till extra bolagsstämma i Spermosens AB 0,01 SEK | -2,50% | 0,10 MSEK

2025-01-14 12:09:27 Spermosens announces relocation to a smaller office at Medicon Village 0,01 SEK | -9,09% | 0,19 MSEK

2024-12-30 11:54:43 Spermosens year-end status update: Strong progress and promising outlook for 2025 0,01 SEK | +21,82% | 0,08 MSEK

2024-12-23 15:00:00 Spermosens announces the last day of trading in BTU and the first day of trading in warrants series TO 5 and TO 6 0,01 SEK | -14,29% | 0,09 MSEK

2024-12-23 08:53:27 Spermosens carries out directed issues of approx. MSEK 5.59, takes up credit facility of MSEK 1.00, and receives proposal of directed issues of approx. MSEK 0.39 0,01 SEK | -14,29% | 0,09 MSEK

2024-12-19 12:21:43 Spermosens announces positive results from ongoing clinical study 0,02 SEK | +51,67% | 0,85 MSEK

2024-11-27 21:00:00 Spermosens publishes outcome in rights issue 0,02 SEK | +4,00% | 0,06 MSEK

2024-11-22 08:00:00 The subscription period in Spermosens' rights issue of units ends on Monday, 25 November 2024 0,01 SEK | -18,75% | 0,10 MSEK

2024-11-20 10:39:48 Spermosens' commercial strategy targets billion-dollar sperm bank market through global partnerships 0,02 SEK | +37,93% | 0,71 MSEK

2024-11-18 14:26:43 Spermosens provides update on clinical study progress 0,01 SEK | -17,33% | 0,05 MSEK

2024-11-11 08:00:00 The subscription period in Spermosens' rights issue of units begins today 0,01 SEK | -23,26% | 0,04 MSEK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Spermosens

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden